Select your language: EN JP

Lux Take on News: Weekly Round-Up March 20, 2020

Lux Research
March 20, 2020

Each week, our analysts gather the biggest headlines and trends and provide their analysis on major industry developments in the news. Our researchers evaluate news based on potential importance ranking developments from Truly Disruptive to Ignore.
Each Friday we will highlight our Lux Take on the news for the week. 

Given the ongoing COVID-19 pandemic, this week we've rounded up commentaries on innovation developments in light of the crisis. For resources to help you tackle innovation challenges in this unprecedented time go to our COVID-19 Innovation Resources page. 

Check out our weekly round-up for the third week of March below.

 

Everlywell to roll out home testing kits for COVID-19

Danielle-Bradnan

Danielle Bradnan, Research Associate | @DBradnan Ico twitter
Lux Take: Truly Disruptive

 
 

"Everlywell has developed a kit for COVID-19 and will launch on March 23, 2020. This is extremely important because it allows the scientific community to get the numbers needed to effectively plan response strategies for the next 18 months – the expected timeline for vaccine distribution. Right now, due to limited access to tests, scientists and policymakers are dealing with a lot of unknowns, including the number of actual cases – as a dearth of tests means many with symptoms are simply asked to stay home to minimize the spread. Everlywell has developed a plan to support a testing capacity of a 250,000 tests per week, which means a greater availability of data, which will in turn inform the next steps in managing this pandemic." Click here to read more.

Opportunities for 3DP industry arises as president of MGH requests 3D-printed masks amid hospital shortages

Tiffany Hua, Research Associate | @tiff_hua Ico twitterTiffany-Hua
Lux Take: Very Important


"Peter Slavin, the president of Massachusetts General Hospital, has asked the larger 3DP community to print masks amid hospital shortages. This is an opportune time for 3D printing companies, print farms, and manufacturing services to leverage their lean manufacturing qualities in this time of crisis. The 3D printing industry has a chance to flex its iterative speed and demonstrate that it is ready for large-scale manufacturing. 3DP companies will need to have a strong ecosystem to produce at scale, in addition to validating their approach with regulatory agencies. Clients that can help respond to this call will not only provide valuable assistance in a crisis but gain valuable production expertise that will pay dividends afterward as well." Click here to read more.

U.S. Center for Medicaid and Medicare Services removes telehealth restrictions in the face of COVID-19

Danielle-Bradnan

Danielle Bradnan, Research Associate | @DBradnan Ico twitter
Lux Take: Truly Disruptive


"Telehealth services will temporarily be reimbursed at rates on par with in-person visits, removing the disincentivization that medical practitioners have previously faced. This comes at a time when it is critical to remove barriers to providing remote care in order to prevent the spread of COVID-19. Clients may believe telehealth has limited opportunities for them, given the stereotype of video cameras and current electronics supply chain problems in China – but they should view mHealth companies (including digital therapeutics) as investment or acquisition targets. These decentralized services are critical now, will retain their value, and because they are software-driven, are not at risk due to breaks in the supply chain." Click here to read more.


Medicago develops COVID-19 vaccine candidate with its plant-based technology in 20 days

Joshua-HaslunJoshua Haslun, Ph.D., Senior Analyst | @JHaslunIco twitter
Lux Take: Very Important


"Medicago has rapidly developed vaccine candidates for RNA viruses previously, including a research-grade influenza vaccine in 2009. That research led to its 2019 submission of a commercializable quadrivalent influenza vaccine to Health Canada. Medicago's technology utilizes plants to produce viruslike particles that mimic viral shape and dimensions to trigger an immune response. Medicago is not the first to develop a candidate vaccine, as China and the NIH began clinical trials, but in a globalized world with inevitable and evolving diseases, companies with rapid development capabilities like Medicago have the chance to demonstrate value. Clients should aggressively pursue such developers for solutions within and outside of human health." Click here to read more.

 

Company that provides erectile dysfunction prescriptions via telemedicine offers COVID-19 assessments – despite appearances, a good thing

Danielle-Bradnan

Danielle Bradnan, Research Associate | @DBradnan Ico twitter
Lux Take: Very Important


"Roman's service has been called into question due to its primary offering of erectile dysfunction prescriptions. Ro is leveraging its existing infrastructure to provide the current best practices of medical care (especially given the absence of available tests) via a nontraditional subscription service. However, it does highlight the fact that patients are left hanging by insurance providers that don't reimburse for telemedicine services. The arrival of COVID-19 should be a wake-up call for the need for reimbursed telehealth services, and a failure to acknowledge this need risks disruption of the healthcare industry by up-and-coming subscription models." Click here to read more.

 

Point-of-care diagnostic that diagnoses COVID-19 in under an hour in development at UCSD

Nardev-Ramanathan

Nardev Ramanathan, Ph.D., Analyst | @Nardev_R Ico twitter
Lux Take: Very Important




"The evolving COVID-19 pandemic is in dire need of rapid actionable tests to mitigate the widespread infection it is causing. While efforts are in full swing across the globe to develop vaccines and scale up production of conventional diagnostic kits, a pressing need right now is to quickly identify and isolate patients to prioritize medical assistance. The fastest diagnostics still take a few hours at best. Researchers at UCSD are working to address this need with a test that can identify a suspected COVID-19 case in 45 minutes, meeting the criteria for a POCD outlined in our recent report. In these trying times, as clients look to invest in or partner with developers, POCD solutions like this must make your shortlist for further vetting." Click here to read more.

 

U.S. Department of Health and Human Services finalizes interoperability rules to permit patient access to health data

Danielle-Bradnan

Danielle Bradnan, Research Associate | @DBradnan Ico twitter
Lux Take: Very Important



"The U.S. Department of Health and Human Services has published interoperability guidelines in accordance with the 21st Century Cures Act. These guidelines, despite contestation by major players in the electronic health record space, now require that patients be able to access their own data via a smartphone API. While opponents have claimed that patients have had access to their records for years, this "accessibility" is largely nonexistent. Having the ability to access and control their data is a critical step for patients to be able to manage their own care, and clients should be looking for ways to support self-managed care by investing in technologies like digital therapeutics and chronic care management platforms." Click here to read more.

 

 

FURTHER READING:

- Blog: Lux Take on News: Weekly Round-Up March 13, 2020

- Blog: 3 Ways The Wuhan Coronavirus Will Not Be The Next Great Influenza

- Lux's COVID-19 Innovation Resources